The effects of PI3K activation are recapitulated clinically in APDS (Activated phosphoinositide 3-kinase delta syndrome (APDS), an autosomal dominant primary human immunodeficiency caused by heterozygous gain-of-function mutations in PIK3CD which encodes the p110δ catalytic subunit of PI3K. Here, PIK3CB is linked to immune system disorder.